Company Overview and News

 
Swaraj Automotives: Offer-for-sale is on

2017-11-21 thehindubusinessline
Shares of Swaraj Automotives (SAL) will remain in focus, as its offer-for-sale to retail investors will close on Wednesday.

 
Opening of Offer for Sale for SWARAJ AUTOMOTIVES LIMITED⠁ctivities Schedule

2017-09-25 indiainfoline
By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in “National Do Not Call Registry” as laid down by “Telecom Regulatory Authority of India” will not be applicable for such information/ communication.

 
Opening of Offer for Sale for Swaraj Automotives Limited

2017-09-25 indiainfoline
By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in “National Do Not Call Registry” as laid down by “Telecom Regulatory Authority of India” will not be applicable for such information/ communication.

 
Swaraj Auto: eyes on stake sale

2017-07-21 thehindubusinessline
The offer-for-sale by b4S Solutions Pvt Ltd, promoter of Swaraj Automotives, will open on Monday (for non-retail investors) and Tuesday (retail investors). They plan to sell 1,60,087 shares to reduce their holding to 75 per cent to meet SEBI’s minimum public shareholding norm.

 
Sebi freezes Swaraj Automotives promoter's voting rights

2017-07-19 business-standard
Taking action against promoter of Swaraj Automotives for non-compliance of minimum public shareholding norms, Sebi on Wednesday ordered freezing of voting rights and all corporate benefits arising out of its excess stake in the company. Sebi has also prohibited the promoter and director of the company from dealing in the shares of Swaraj Automotives except for meeting the minimum 25 per cent public shareholding limit till the time of their compliance to this requirement.

 
Sebi freezes Swaraj Automotives promoter#39;s voting rights

2017-07-19 moneycontrol
Taking action against promoter of Swaraj Automotives for non-compliance of minimum public shareholding norms, Sebi on Wednesday ordered freezing of voting rights and all corporate benefits arising out of its excess stake in the company.

 
Withdrawal of Offer for Sale of Swaraj Automotives Limited

2017-06-19 indiainfoline
This is in continuation of the notice no. 20170619-10 dated June 19, 2017 for Offer for Sale (OFS) by b4S Solutions Private Limited, Seller Promoter of Swaraj Automotives Limited, (“the Company”), through Stock Exchange Mechanism for 160,087 equity shares of the Company Swaraj Automotives Limited of face value Rs.10/- each on 20th June, 2017 for Non- Retail Investors and 21st June, 2017 for Retail Investors and Non-Retail Investors who choose to carry forward their bids.

 
Opening of Offer for Sale for Swaraj Automotives Limited

2017-06-19 indiainfoline
Trading and Custodian Members of the Exchange are requested to refer to notice nos. 20160218-33 dated February 18, 2016, detailing Revised Guidelines for Bidding in Offer for Sale (OFS) Segment. The above guidelines were issued by the Exchange with reference to Securities and Exchange Board of India (SEBI) circular no. CIR/MRD/DP/36/2016 dated February 15, 2016, regarding “Review of Offer for Sale (OFS) of Shares through Stock Exchange Mechanism”.

 
Swaraj Auto: promoter launches offer-for-sale

2017-01-30 thehindubusinessline
Shares of Swaraj Automotives will remain on investors’ radars, as the offer-for-sale (OFS) by promoter b4S Solutions, is currently on. It plans to sell 1.79 lakh shares, representing 7.46 per cent of the share capital of the company, on January 30 (to non-retail investors) and January 31 (to retail investors).

 
Opening of Offer for Sale for Swaraj Automotives Limited

2017-01-04 indiainfoline
Trading and Custodian Members of the Exchange are requested to refer to notice nos. 20160218-33 dated February 18, 2016, detailing Revised Guidelines for Bidding in Offer for Sale (OFS) Segment. The above guidelines were issued by the Exchange with reference to Securities and Exchange Board of India (SEBI) circular no. CIR/MRD/DP/36/2016 dated February 15, 2016, regarding “Review of Offer for Sale (OFS) of Shares through Stock Exchange Mechanism”.

 
Stocks in news: Cipla, Gitanjali, Mandhana Retail, NALCO, Jagran

2016-12-15 moneycontrol
Cipla | Gitanjali Gems | S H Kelkar | Swaraj Automotives | Welspun India | Mandhana Retail | MBL Infra | NALCO | Nectar Life and Jagran Prakashan are stocks, which are in the news today.

 
Swaraj Automotives: Promoter to sell stake

2016-12-14 thehindubusinessline
4S Solutions Private Ltd, sole promoter of Swaraj Automotives, proposes to sell 3.18 lakh equity shares, representing 13.28 per cent of its share capital, through a offer-for-sale window on the BSE. The company fixed the floor price at ₹150 a share. Non-retail Investors will be allowed to place their bids on December 15; retail investors and non-retail investors who choose to carry forward their bids can place their orders on December 16.

 
Monsoon forecast 2016: Sectors, stocks that will benefit from above normal rains

2016-04-13 financialexpress
Anticipation of healthy monsoon in 2016 boosted market sentiments as the broader market index NSE Nifty crossed the psychological level of 7,800 on Wednesday for the first time since January 6. The benchmark index BSE Sensex was also trading over 400 points up in morning trade.

 
Swaraj Automotives shifts registered office

2016-02-08 indiainfoline
With effect from 01 April 2016

 
M&M completes stake sale in Swaraj Automotives

2016-02-02 thehindubusinessline
Homegrown auto major Mahindra & Mahindra today said it has completed the sale of i

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...